SEC Filing Update: #LONA LeonaBio, Inc. : $7.92

Sector: Healthcare | YTD: 🔼+ 13.14% The SEC disclosed Today (31-AUG-2026) that Sermonix Pharmaceuticals, Inc. has Newly bought 5,502,402 #LONA shares Ownership: 36.9% * Estimated Investment Value: $43.30M https://www.thinksabio.com/reports/isr/LONA Institutional ownership in #LONA has been steadily rising over the past 4 quarters in Shares: Q3 2025: 1.72M Q4 2025: 6.21M Q1 2026: 6.45M Q2 2026: 7.04M 📌 Institutional activity in the last 30 days for #LONA: • ACORN BIOVENTURES, L.P.  – Increased holdings by 230,305 shares (20-AUG-2026) • PERCEPTIVE ADVISORS LLC – Increased holdings by 30,081 shares (25-AUG-2026) 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2094528359115927775 Sermonix Pharmaceuticals, Inc. acquired 5,502,402 shares of Longeveron Inc., increasing its ownership stake to 36.9% from a previous position of 0 shares.